QT Sense is a provider of confocal microscopy technology to measure free radicals in stressed cells. The company has developed a unique confocal microscope technology that enables high-resolution imaging of cells and tissues, specifically focused on detecting and measuring free radical activity. This technology has applications in medical research, drug development, and diagnostic applications where understanding oxidative stress at the cellular level is critical. Founded in 2024 and headquartered in Groningen, Netherlands, QT Sense has raised approximately 9.8 million at the Seed stage with 23 employees and investors including QDNL Participations, interregeurope.eu, Cottonwood Technology Fund, Quantum Delta, and UMCG.
← All startups
QT Sense
SeedQT Sense is a provider of confocal microscopy technology to measure free radicals in stressed cells. The company has developed a unique confocal microscope technology that enables high-resolution imaging of cells and tissues, specifically focused on detecting and measuring free radical activity. This technology has applications in medical research, drug development, and diagnostic applications where understanding…
About
Institutional investors
QDNL Participationsinterregeurope.euCottonwood Technology FundQuantum DeltaUMCG
Latest coverage
📰 Latest funding news — recent raises and deal signals across the ecosystem.
Investor directory
🗂️ Full list of active funds — filter by stage, check size, and geography.